Serum amyloid A is an innate immune opsonin for Gram-negative bacteria

Blood

Volumn 108, Issue 5, 2006, Pages 1751-1757

  Shah, Chandrabala ^a   Hari Dass, Ranjeeta ^a   Raynes, John G ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; OPSONIN; OXYGEN; REACTIVE OXYGEN METABOLITE; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMORAL IMMUNITY; INNATE IMMUNITY; MACROPHAGE; MUTATION; NEUTROPHIL; NONHUMAN; OPSONIZATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PSEUDOMONAS AERUGINOSA; RESPIRATORY BURST;

EID: 33748136434     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-11-011932     Document Type: Article

References (36)

1. Uhlar CM, Whitehead AS. SAA, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;265:501-523.
2. Morrow JF, Stearman RS, Peltzman CG, Potter DA. Induction of hepatic synthesis of SAA protein and actin. Proc Natl Acad Sci U S A. 1981;78:4718-4722.
3. Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y. Widespread expression of SAA in histologically normal human tissues: predominant localization to the epithelium. J Histochem Cytochem. 1998;46:1377-1384.
4. Santiago-Cardona PG, Berrios CA, Ramirez F, Garcia-Arraras JE. Lipopolysaccharides induce intestinal SAA expression in the sea cucumber Holothuria glaberrima. Dev Comp Immunol. 2003;27:105-110.
5. Benditt EP, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci U S A. 1977;74:4025-4028.
6. Su SB, Gong W, Gao JL, et al. A seven-transmembrane G protein-coupled receptor, FPRL1, mediates the chemotactic activity of SAA for human phagocytic cells. J Exp Med. 1999;189:395-402.
7. Badolato R, Wang JM, Murphy WJ, et al. SAA is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med. 1994;180:203-209.
8. He R, Sang H, Ye RD. SAA induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood. 2003;101:1572-1581.
9. Brinckerhoff CE, Mitchell TI, Karmilowicz MJ, Kluve-Beckerman B, Benson MD. Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins. Science. 1989;243:655-657.
10. Vallon R, Freuler F, Desta-Tsedu N, et al. SAA expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metallo-proteinases. J Immunol. 2001;166:2801-2807.
11. 2. Biochem J. 1995;309:461-464.
12. Badolato R, Wang JM, Stornello SL, Ponzi AN, Duse M, Musso T. SAA is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity. J Leukoc Biol. 2000;67:381-386.
13. Cai L, de Beer MC, de Beer FC, van der Westhuyzen DR. SAA is a ligand for scavenger receptor class B type I and inhibits HDL binding and selective lipid uptake. J Biol Chem. 2005;280:2954-2961.
14. Baranova IN, Vishnyakova TG, Bocharov AV, et al. SAA binding to CLA-1 (CD36 and LIMPII analogous-1) mediates SAA protein-induced activation of ERK1/2 and p38 MAP kinases. J Biol Chem. 2005;280:8031-8040.
15. Walder K, Kantham L, McMillan JS, et al. Tanis: a link between type 2 diabetes and inflammation? Diabetes. 2002;51:1859-1866.
16. Yan SD, Zhu H, Zhu A, et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med. 2000;6:643-651.
17. Urieli-Shoval S, Shubinsky G, Linke RP, Fridkin M, Tabi I, Matzner Y. Adhesion of human platelets to SAA. Blood. 2002;99:1224-1229.
18. Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. SAA binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. J Immunol. 1996;156:1189-1195.
19. Ancsin JB, Kisilevsky R. Characterization of high affinity binding between laminin and the acute-phase protein, SAA. J Biol Chem. 1997;272:406-413.
20. Ancsin JB, Kisilevsky R. The heparin/heparan sulphate-binding site on apo-SAA: implications for the therapeutic intervention of amyloidosis. J Biol Chem. 1999;274:7172-7181.
21. Hari-Dass R, Shah C, Meyer DJ, Raynes JG. SAA protein binds to outer membrane protein A of Gram-negative bacteria. J Biol Chem. 2005;280:18562-18567.
22. Raynes JG, McAdam KP. Purification of SAA and other high density apolipoproteins by hydrophobic interaction chromatography. Anal Biochem. 1988;173:116-124.
23. Puohiniemi R, Karvonen M, Vuopio-Varkila J, Muotiala A, Helander IM, Sarvas M. A strong antibody response to the periplasmic C terminal domain of E coli is produced by immunisation with OmpA or whole E coli or Salmonella typhimurium bacteria. Infect Immun. 1990;58:1691-1696.
24. Kurupati P, Teh BK, Kumarasinghe G, Poh CL. Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis. Proteomics. 2006;6:836-844.
25. Rodriguez JA, Bodman-Smith KB, Raynes JG. Neutrophil responses to CRP are not dependent on polymorphism of human FcγRIIA (R131H). Clin Exp Immunol. 2004;138:271-277.
26. Barter PJ, Nicholls S, Rye KA, Anatharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004;95:764-772.
27. Marhaug G, Hackett B, Dowton SB. Serum amyloid A expression in rabbit, mink and mouse. Clin Exp Immunol. 1997;107:425-434.
28. Ogawa H, Fukushima K, Sasaki I, Matsuno S. Identification of genes involved in mucosal defence and inflammation associated with normal enteric bacteria. Am J Physiol Gastrointest Liver Physiol. 2000;279:G492-G499.
29. Vreugdenhil AC, Dentener MA, Snoek AM, Greve JW, Buurman WA. Lipopolysaccharide binding protein and SAA secretion by human intestinal epithelial cells during the acute phase response. J Immunol. 1999;163:2792-2798.
30. Larson MA, Wei SH, Weber A, Weber AT, McDonald TL. Induction of human mammary-associated SAA3 expression by prolactin or lipopolysaccharide. Biochem Biophys Res Commun. 2003;301:1030-1037.
31. Jeannin P, Renno T, Goetsch L, et al. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat Immunol. 2000;1:502-509.
32. Soulas C, Baussant T, Aubry JP, et al. OmpA binds to and activates human macrophages. J Immunol. 2000;165:2335-2340.
33. Prasadarao NV, Srivastava PK, Rudrabhatla RS, Kim KS, Huang S, Sukumaran SB. Cloning and expression of the E coli K1 outer membrane receptor, a gp96 homologue. Infect Immun. 2000;71:1680-1688.
34. Prasadarao NV. Identification of E. coli outer membrane protein A receptor on human brain microvascular endothelial cells. Infect Immun. 2002;70:4556-4563.
35. Hellman J, Loiselle PM, Tehan MM, et al. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect Immun. 2000;68:2566-2572.
36. Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 2004;23:4538-4549.